Entry and the Number of Firms in the Swedish Pharmaceutical Market PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Entry and the Number of Firms in the Swedish Pharmaceutical Market PDF full book. Access full book title Entry and the Number of Firms in the Swedish Pharmaceutical Market by Niklas Rudholm. Download full books in PDF and EPUB format.

Entry and the Number of Firms in the Swedish Pharmaceutical Market

Entry and the Number of Firms in the Swedish Pharmaceutical Market PDF Author: Niklas Rudholm
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 20

Book Description


Entry and the Number of Firms in the Swedish Pharmaceutical Market

Entry and the Number of Firms in the Swedish Pharmaceutical Market PDF Author: Niklas Rudholm
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 20

Book Description


Entry and the Number of Firms in the Swedish Pharmaceuticals Market

Entry and the Number of Firms in the Swedish Pharmaceuticals Market PDF Author: Niklas Rudholm
Publisher:
ISBN:
Category :
Languages : en
Pages :

Book Description


Pharmaceutical Market Access in Developed Markets

Pharmaceutical Market Access in Developed Markets PDF Author: Güvenç Koçkaya
Publisher: SEEd
ISBN: 8897419747
Category : Medical
Languages : en
Pages : 325

Book Description
Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. It covers a group of activities intended to provide access to the appropriate medicine for the appropriate group of patients at the appropriate price (in most countries). Market Access may also be seen as activities that support the management of potential barriers, such as non-optimal price and reimbursement levels, the restriction of the scope of prescribing for the drug or complicated prescription writing or funding procedures. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in our previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics, industry personnel, government workers, and decision makers understand the environment in developed markets.

Incentives for Research, Development, and Innovation in Pharmaceuticals

Incentives for Research, Development, and Innovation in Pharmaceuticals PDF Author: Walter A. Garcia-Fontes
Publisher: Springer Science & Business Media
ISBN: 8493806277
Category : Medical
Languages : en
Pages : 105

Book Description
Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

Handbook of Health Economics

Handbook of Health Economics PDF Author: Mark V. Pauly
Publisher: Elsevier
ISBN: 0444535926
Category : Business & Economics
Languages : en
Pages : 1149

Book Description
"As a relatively new subdiscipline of economics, health economics has made many contributions to areas of the main discipline, such as insurance economics. This volume provides a survey of the burgeoning literature on the subject of health economics." {source : site de l'éditeur].

Making Medicines Affordable

Making Medicines Affordable PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Internationalization, Market Power and Consumer Welfare

Internationalization, Market Power and Consumer Welfare PDF Author: Yves Bourdet
Publisher: Taylor & Francis
ISBN: 1040166563
Category : Business & Economics
Languages : en
Pages : 383

Book Description
In the years prior to this book being originally published in 1992, the study of industrial economics had been dominated by the USA. While there was a fund of theoretical and empirical knowledge relating to the US experience, this is not always relevant in the context of Europe. With its considerable national market the USA developed competition policies that differ from those in the smaller economies of European countries. This collection of essays looks at the market behaviour of an economy more open to international competition. The industrial organization of Sweden provides the ideal representation of smaller economies that can be applied to the other economies of western Europe. The contributors apply different analytical approaches to assess direct and indirect forms of market power. Some papers draw on econometric cross-sectional models exploring the scope of market power and the role of international competition. Others look at specific markets investigating the formation of market power – its costs to consumers and the role of lobbying groups and the political sphere: case studies include the domestic car, white goods, pharmaceutical goods, food, textile and air transport markets. The book also contains papers that examine the role of competition policy towards restrictive practices and mergers in curbing market power and promoting economic efficiency. This book will be of interest to those studying industrial economics and international business and marketing.

Non-Linear Time Series

Non-Linear Time Series PDF Author: Kamil Feridun Turkman
Publisher: Springer
ISBN: 3319070282
Category : Mathematics
Languages : en
Pages : 255

Book Description
This book offers a useful combination of probabilistic and statistical tools for analyzing nonlinear time series. Key features of the book include a study of the extremal behavior of nonlinear time series and a comprehensive list of nonlinear models that address different aspects of nonlinearity. Several inferential methods, including quasi likelihood methods, sequential Markov Chain Monte Carlo Methods and particle filters, are also included so as to provide an overall view of the available tools for parameter estimation for nonlinear models. A chapter on integer time series models based on several thinning operations, which brings together all recent advances made in this area, is also included. Readers should have attended a prior course on linear time series, and a good grasp of simulation-based inferential methods is recommended. This book offers a valuable resource for second-year graduate students and researchers in statistics and other scientific areas who need a basic understanding of nonlinear time series.

Innovation and Marketing in the Pharmaceutical Industry

Innovation and Marketing in the Pharmaceutical Industry PDF Author: Min Ding
Publisher: Springer Science & Business Media
ISBN: 1461478014
Category : Medical
Languages : en
Pages : 763

Book Description
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.

Market Entry Strategies

Market Entry Strategies PDF Author: Mario Glowik
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 3110653117
Category : Business & Economics
Languages : en
Pages : 179

Book Description
This entirely revised and updated third edition of Market Entry Strategies continues to combine the profound explanation of internationalization theories and concepts with real-life firm cases. Reviewing the readers’ valuable feedback from successful previous editions this version targets to improve the readability. New firm cases of Delivery Hero and Tesla contribute to broaden the books’ industry focus. Particular attention is paid on the case studies developed to exercise in light of business practice what is theoretically taught and explained in the textbook. Through its link to digital learning tools such as charts available to the public at YouTube this new edition provides best pre-requisites for distance learning environments.